Triggering of Fas (CD95) by its ligand (FasL) rapidly induces cell death via recruitment of the adaptor protein Fas-associated death domain (FADD), resulting in activation of a caspase cascade. It was thus surprising that T lymphocytes deficient in FADD were reported recently to be not only resistant to FasL-mediated apoptosis, but also defective in their proliferative capacity. This finding suggested potentially dual roles of cell growth and death for Fas and possibly other death receptors. We report here that CD3-induced proliferation and interleukin 2 production by human T cells are blocked by inhibitors of caspase activity. This is paralleled by rapid cleavage of caspase-8 after CD3 stimulation, but no detectable processing of caspase-3 during the same interval. The caspase contribution to T cell activation may occur via TCR-mediated upregulation of FasL, as Fas-Fc blocked T cell proliferation, whereas soluble FasL augmented CD3-induced proliferation. These findings extend the role of death receptors to the promotion of T cell growth in a caspase-dependent manner.
Skip Nav Destination
Article navigation
20 December 1999
Brief Definitive Report|
December 20 1999
Caspase Activation Is Required for T Cell Proliferation
Norman J. Kennedy,
Norman J. Kennedy
aImmunobiology Program, Department of Medicine, The University of Vermont College of Medicine, Burlington, Vermont 05405
Search for other works by this author on:
Takao Kataoka,
Takao Kataoka
bInstitute of Biochemistry, University of Lausanne, BIL Biomedical Research Center, CH-1066 Epalinges, Switzerland
Search for other works by this author on:
Jürg Tschopp,
Jürg Tschopp
bInstitute of Biochemistry, University of Lausanne, BIL Biomedical Research Center, CH-1066 Epalinges, Switzerland
Search for other works by this author on:
Ralph C. Budd
Ralph C. Budd
aImmunobiology Program, Department of Medicine, The University of Vermont College of Medicine, Burlington, Vermont 05405
bInstitute of Biochemistry, University of Lausanne, BIL Biomedical Research Center, CH-1066 Epalinges, Switzerland
Search for other works by this author on:
Norman J. Kennedy
aImmunobiology Program, Department of Medicine, The University of Vermont College of Medicine, Burlington, Vermont 05405
Takao Kataoka
bInstitute of Biochemistry, University of Lausanne, BIL Biomedical Research Center, CH-1066 Epalinges, Switzerland
Jürg Tschopp
bInstitute of Biochemistry, University of Lausanne, BIL Biomedical Research Center, CH-1066 Epalinges, Switzerland
Ralph C. Budd
aImmunobiology Program, Department of Medicine, The University of Vermont College of Medicine, Burlington, Vermont 05405
bInstitute of Biochemistry, University of Lausanne, BIL Biomedical Research Center, CH-1066 Epalinges, Switzerland
N.J. Kennedy and T. Kataoka contributed equally to this work.
Received:
March 18 1999
Accepted:
November 02 1999
Online ISSN: 1540-9538
Print ISSN: 0022-1007
© 1999 The Rockefeller University Press
1999
The Rockefeller University Press
J Exp Med (1999) 190 (12): 1891–1896.
Article history
Received:
March 18 1999
Accepted:
November 02 1999
Citation
Norman J. Kennedy, Takao Kataoka, Jürg Tschopp, Ralph C. Budd; Caspase Activation Is Required for T Cell Proliferation. J Exp Med 20 December 1999; 190 (12): 1891–1896. doi: https://doi.org/10.1084/jem.190.12.1891
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement